Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Desensin
- Development stage
- Unknown
- Lead developer
- Dentaid
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Administration
- Topical
01
Overview
Desensin is a line of desensitizing oral care products developed by Dentaid specifically for the management of dentin hypersensitivity and sensitive teeth. The product range includes toothpastes and gels designed for daily topical oral application. The primary mechanism of action involves potassium nitrate, which acts by increasing extracellular potassium ion concentration around nerve endings, thereby inhibiting the transmission of external stimuli and reducing pain. Some variants, such as Desensin Repair, utilize DENTAID Nanorepair technology, which incorporates hydroxyapatite nanoparticles to physically occlude exposed dentinal tubules and repair the enamel surface. Additionally, the formulations typically include sodium fluoride for enamel remineralization and anticaries protection, along with Provitamin B5, Allantoin, and Vitamin E to support gum health and tissue regeneration.
- Brand names
- DesensinDesensin RepairDesensin PlusDesensin Soft
- Other names
- Desensin sensitive teeth products
Beyond the preview
Go deeper on Desensin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Desensin.